Novo-Hims GLP-1 deal, CVS 340B ruling and FDA drug pricing push top today’s news

March 9, 2026

1. Novo, Hims strike GLP-1 deal after legal feud Full story

2. FDA, states review plans to import drugs from Canada Full story

3. Where pharmacy margin and control slip away inside health systems — and how leaders can respond, here.

 

4. Judge dismisses Pennsylvania hospitals' lawsuit over CVS' 340B practices Full story

5. U of Kentucky names 2 specialty pharmacy directors Full story

6. Drug costs rise, shortages persist and 340B scrutiny grows. How Vernon Memorial Healthcare aligns procurement here.

 

7. Eli Lilly launches direct-to-employer GLP-1 platform Full story

8. FDA vaccine chief to step down in April Full story

9. 10 top patient safety concerns in 2026: ECRI Full story

10. UChicago Medicine develops mRNA therapy for Type 1 diabetes Full story

11. 11 large health systems growing bigger Full story

 

12. Outpatient + specialty pharmacies face new 340B billing challenges. See what's changing here.

Becker's Learning Opportunities

13. Health systems are redefining specialty medication access with integrated solutions. Learn how here.

14. CFOs: Strengthen medication cost visibility with pharmacy partnership insights. Learn how here.

15. High-acuity overuse is escalating total cost of care. What's fueling new behavioral health designs here.

16. Interested in more? See Becker’s full lineup of webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication